See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Aug. 4, 2003

Irritable Bowel Syndrome (IBS) Migraine and Cluster Headaches Head and Neck Cancer

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Irritable Bowel Syndrome (IBS)

A research study of an investigational medication for irritable bowel syndrome (IBS). Female volunteers at least 18 years old who have suffered from the diarrhea-predominant type of IBS for at least 6 months and have failed conventional therapy may be eligible. Research site located in Atlanta, Georgia.

More Information

Please see http://www.centerwatch.com/patient/studies/cat90.html.

-----

Migraine and Cluster Headaches

A study to evaluate the efficacy, safety, and tolerability of an investigational medication versus placebo in the treatment of migraine headaches. Volunteers between 16 and 65 who have been clinically diagnosed with migraine headaches with and without aura for at least one year prior to study may be eligible. Research site located in Philadelphia, Pennsylvania.

More Information

Please see http://www.centerwatch.com/patient/studies/cat100.html.

-----

Head and Neck Cancer

A study to test the effectiveness of two investigational medications in treating patients who have head and neck cancer that has come back or has spread to other parts of the body. Volunteers at least 18 years old who have a measurable disease and who have not had a chemotherapy treatment for at least 4 weeks may be eligible. Research site located in Bethlehem, Pennsylvania.

More Information

Please see http://www.centerwatch.com/patient/studies/cat161.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.